# Type I vs Type IV Latex Allergy and Skin-Contact Labeling Reality
Human page: https://retifist.com/literature-reviews/allergy-and-skin-contact
> **Not medical advice.** This article is literacy: names for reaction *classes*, typical *timing patterns*, and what labels do or do not mean. It is **not** diagnosis, treatment, emergency protocol, or a product “safe to wear” certificate. Seek a qualified clinician for symptoms. Do not self-diagnose, self-treat, or treat any sheet, bottle, or garment as medically cleared.
## Executive summary
“Latex allergy” covers three different patterns. One is an immediate reaction to **proteins** in natural rubber latex (NRL). Another is a delayed contact reaction to **cure chemicals** (accelerators and related additives). A third is **irritant** dermatitis, which is not that immune allergy. Collapsing them into one bucket leads to the wrong avoidance and to false safety from “hypoallergenic,” “FDA,” or “food-contact” talk.
Medical **devices** that contain natural rubber latex must carry a specific caution and must not say “hypoallergenic” on that NRL device.[^1] Fashion sheet, craft liquid, and catsuits typically sit **outside** that rule. Food-contact rubber tables list accelerators for **food**; they are not dermal wear clearance.[^2]
Use this before first skin-contact wear, when choosing a **liquid latex work** bottle, when a seller says “hypoallergenic” or “FDA,” or when a rash appears after wearing. **This article is literacy, not medical advice.**
---
## Three reaction classes (literacy only)
> **Not medical advice.** Timing and class names below are **literacy**, not a self-test. Overlapping rashes happen. Do not diagnose from a clock.
NIOSH’s 1997 Alert on NRL gloves and other NRL products separates three patterns:[^3]
| Class (literacy name) | What the source is talking about | Typical timing *pattern* (not diagnosis) |
| --- | --- | --- |
| Irritant contact dermatitis | Skin irritation from gloves, washing, powder; **not** true allergy | Literacy gloss: often during or soon after exposure; not an IgE “latex allergy” label. NIOSH does not pin that clock. |
| Delayed / Type IV-like (allergic contact dermatitis) | Reaction to **processing chemicals**, not to the rubber proteins | Usually **24–48 h** after contact in NIOSH’s wording |
| Immediate / Type I (NRL protein) | Immune reaction to **NRL proteins**; minutes to hours in previously sensitized people | Minutes to hours; can include systemic immediate reactions |
NIOSH: NRL **proteins** can cause allergic reactions; **processing chemicals** added during manufacturing can cause skin rashes; products called “latex” that are synthetics do **not** release those NRL proteins.[^3] OSHA’s hospital eTool uses the same three-way split (irritant vs allergic contact vs immediate) and warns: do **not** assume hypoallergenic or powderless gloves are non-latex.[^4] OSHA’s 2008 SHIB points back to NIOSH 97-135 and notes NRL beyond exam gloves. That is still a **workplace** frame, not fashion epidemiology.[^5]
Clinical reviews use the same split: Hevea proteins → Type I; processing chemicals / antioxidants → Type IV.[^6][^7][^8] Public literacy from AAAAI: delayed-type contact dermatitis often **12–36 h**, usually from **added chemicals**; immediate reactions in previously sensitized people; anaphylaxis named as a *severe immediate* pattern.[^9] AAAAI’s glossary: immune overreaction to **proteins** in NRL; synthetic “latex” paints not shown to pose that protein hazard to latex-sensitive individuals.[^10]
**Do not** copy treatment or epinephrine instructions from those pages into this article. **Not medical advice.**
Storage/oils pointer only (not diagnosis): [Aging, Storage and Care](/literature-reviews/aging-storage-and-care).
---
## Timing literacy (not diagnosis)
- **Immediate / protein (Type I literacy):** minutes to hours after contact in NIOSH’s triad;[^3] AAAAI: immediate reactions in previously sensitized people.[^9]
- **Delayed / chemical (Type IV literacy):** NIOSH: allergic contact dermatitis from chemicals, usually **24–48 h**.[^3] AAAAI public page: delayed-type contact dermatitis **12–36 h**, usually added chemicals.[^9] Those windows **overlap in the real world**. A clock is not a lab test.
- **Irritant:** NIOSH lists irritant contact dermatitis as **not** true allergy.[^3] Ammonia odor on **liquid latex work** concentrate can cause **human discomfort** (especially above 0.3% ammonia in the Practical Guide’s wording) and is **not** Type I or Type IV in that composition discussion.[^11]
If a wearer or maker notices a new rash, hives, breathing trouble, or swelling after latex contact, **stop wearing / stop compounding that article and seek clinical care**. That sentence is a literacy stop-rule, **not** a treatment protocol and **not** a handbook SOP.
---
## What is in the film (categories, not personal risk scores)
### Proteins (NRL feedstock)
Fresh NRL is not “just rubber.” Table 2.1: rubber 30–35%; **proteins 1–1.5%**, plus resins, carbohydrates, minerals, water.[^11] The rubber particle surface is covered by a **protein-lipid envelope**; lutoid membranes are protein.[^11] Historical 1932 picture: adsorbed **protein** layer / exterior protein shell, important in **acid coagulation**. That is composition and coagulation, **not** allergy medicine.[^12]
**Sheet-based work and liquid latex work both** start from Hevea NRL if the product is natural rubber. How much **extractable** protein remains in a **fashion sheet** or a home-cast film is not established in this pack. Glove protein QC is a different lineage.
AAAAI: “latex allergy” in the protein sense is an immune overreaction to **proteins** in NRL.[^10] ASTM D6499’s significance statement (method class): Type I from HNRL **proteins** vs Type IV from **chemical additives**.[^13]
### Accelerator families (compounding)
Organic accelerators plus zinc oxide enable fast latex-film cure; many are active below 100 °C.[^14] Handbook Table 1 types include thiuram, dithiocarbamate, xanthate, thiazole (including sulfenamide), thiourea, guanidine. Dithiocarbamates are the fastest and most used for latex; thiazoles and thiurams are too slow alone and are used as secondaries.[^14] Practical Guide: metallic/amine dialkyl dithiocarbamates, thiazoles, and thiurams as secondary; named examples include ZDEC (ZEDC), ZMBT, TMTM, tetraethylthiuram disulfide, and DPTD.[^11]
Clinical Type IV lists match those **families**, not a fashion SKU: carbamates, thiuram mix, 2-mercaptobenzothiazole (2-MBT), 1,3-diphenylguanidine among common patch positives;[^7] Type IV ACD from thiurams, carbamates, mercaptobenzothiazoles.[^8] Thiurams were historically frequent in glove ACD; industry shifted toward dithiocarbamates; thiuram↔dithiocarbamate redox / cross-reactivity keeps “thiuram allergy” relevant.[^15]
Blackley’s *Application of Latices* Vol. 3 §16.3.7 states that with more vulcanized rubber contacting skin, **dermatitis** from certain **vulcanization accelerators** (and antioxidants) has drawn increasing concern; a localized reaction can **generalize** so the whole body surface becomes sensitized.[^23] Gloves and condoms are named as the latex-derived products of greatest concern because they are in **intimate skin contact** during use — still an **industrial/clinical** frame, not fashion catsuit epidemiology. Wilson patch tests on **42 clinic patients**: positive reactions included dipentamethylenethiuram disulphide (30), tetramethylthiuram disulphide (20), 2-mercaptobenzthiazole (15), and zinc diethyldithiocarbamate (2).[^23] Do **not** treat those counts as fashion-sheet incidence.
Hansen et al. pooled **dermatitis-clinic** prevalences (thiuram mix ~2.55%; mercapto mix ~0.86%; MBT ~0.83%; carba mix ~3.96% in an extended series). That is a **clinic population, not garment wearers**.[^16] Do **not** treat those percentages as fashion-catsuit incidence.
**Liquid latex work concentrate note:** a popular low-ammonia (LATZ) system is 0.2% ammonia + 0.0125% each **TMTD** and ZnO + 0.05% lauric acid.[^11] HPL Vol. 3 flags low-ammonia NR with a **thiuram sulphide or dithiocarbamate secondary preservative** as an example to avoid when designing goods for human contact.[^23]
**SDS class ≠ diagnosis.** A representative zinc bis(diethyldithiocarbamate) (ZDEC, CAS 14324-55-1) laboratory SDS: GHS Skin Sens. 1; **H317** “May cause an allergic skin reaction.”[^17] That is the **neat chemical’s hazard class**, not a diagnosis of a worn garment.
---
## What labels mean (devices vs fashion)
21 CFR **801.437** is **medical-device NRL labeling**. Scope in the rule: devices that contain natural rubber latex contacting humans. Proteins are the hazard named in (a). Required user labeling includes a bold caution: this product contains natural rubber latex which may cause allergic reactions. **(h) the labeling shall not contain the term “hypoallergenic.”** Noncompliance is misbranding under the rule’s (j).[^1]
The 1997 final rule explains the caution on medical devices/packaging containing NRL or dry natural rubber contacting humans, and why hypoallergenicity claims were removed: Draize-type tests were inappropriate for protein sensitivity.[^18] OSHA’s eTool cites 801.437 in the hospital-glove setting.[^4]
If a catsuit, sheet roll, or craft bottle **lacks** a device-style NRL caution, that absence is **not** evidence that the product is protein-free or accelerator-free. If a fashion listing says “hypoallergenic,” that word is **not** the 801.437 device prohibition being satisfied. Fashion is typically **outside** that rule. The word is **not** a Type I / Type IV clearance.
---
## Food-contact FDA ≠ wear certification
21 CFR **177.2600** is *Rubber articles intended for repeated use* in **producing, packing, or holding food**. Accelerator listings and a total cap (**not to exceed 1.5% by weight of rubber product**) live under that food-contact rule, with extractive limits and a cleanse-before-first-food-use note.[^2] Vanderbilt reprints the same food-contact identity map (thiazoles, dithiocarbamates, thiurams, guanidines as accelerators, “not to exceed 1.5% by weight of rubber product”).[^14] Antidegradants appear under a separate food-contact cap (example: “as antioxidant, not to exceed 5% by weight of rubber product”).[^14] **None of those rows is a dermal wear or allergy certificate.**
Clinical Type IV to antioxidants is an **external** literature topic (Nucera lists antioxidants among Type IV contactants).[^7]
Do not treat a food-contact table row, an “FDA” badge on a listing, or “skin-safe” marketing as dermatological approval.
---
## Sheet-based work vs liquid latex work: leach, powder, and what does *not* transfer
Advice **differs** here. Do not apply glove-leach language to a bought roll, or fashion-sheet silence to a dipped former line.
### Liquid latex work — dipped / coagulant goods
For latex-dipped products intended to contact the **human body**, Blackley’s dipping-formulation chapter says the vulcanizing system should be designed to **minimize N-nitrosamines and N-nitrosatable amines**.[^23] That is a **liquid latex work industrial formulation principle** for gloves, condoms, and similar dipped lines — not a home cast-and-wear SOP.
A warm-water leach tank is **required for coagulant-dipped products**; circulate; do not reuse leach water unless leached materials are removed.[^14] The stated purpose of warm-water leach is to extract **coagulant** from the wet gelled latex film; more thorough leach → higher cured film properties, better aging, less discoloration. That leach discussion does **not** say it reduces Type I protein.[^14]
Protein language is on the **Practical Guide glove** line: pre-cure leach (~80 °C) “removes the excess chemicals.” **Post-leach:** leach again in hot water to “remove the water-soluble protein and chemicals” so residual protein of **gloves** is kept to a minimum.[^11] Glove performance lists include protein content and antigenic protein content. A named functional defect: increased protein levels from insufficient leaching or high protein latex.[^11]
NIOSH: **powder binds proteins** (Type I amplifier in the glove/occupational story).[^3] FDA banned powdered surgeon’s / patient-exam gloves and absorbable lubricating powder; NRL allergen on powder is among the named risks. **Non-powdered NRL gloves still use §801.437.** This is **not** a fashion-garment powder ban.[^19]
A maker who **dips** (liquid latex work) inherits the *idea* that leach extracts water-soluble stuff from a wet gel. Copying tank temperatures, dwell, or “this dip is medical-glove protein grade” without a measured method is **not** supported.
### Sheet-based work — commercial sheet / finished fashion garments
Extractable protein, antigenic protein, and residual accelerators in **commercial fashion sheet** vs medical gloves: no primary dataset in this pack. Path A calendered-sheet **leach history** vs Path B dipped post-leach: industrial leach texts are glove/dipped.
**Both paths (same advice):** Type I vs Type IV literacy, no DIY patch test, food-contact ≠ wear cert, 801.437 is a **device** rule, stop-and-seek-care if symptoms.
ISO 12243 assays water-extractable protein in NR **medical gloves**; the standard does **not** address safety or labelling; extraction for **non-glove** NR articles is **not validated**.[^20] You cannot convert a glove protein number into garment safe/unsafe.
Glue-family pointer: [Adhesives and Seam Integrity](/literature-reviews/adhesives-and-seam-integrity).
---
## Buyer / maker checklist (questions, not self-tests)
**Not medical advice.** Do **not** DIY patch-test a garment or bottle on skin to “see if you’re allergic.”
| Ask | Why it matters | What silence means |
| --- | --- | --- |
| Is this **natural rubber latex** (Hevea NRL), or a synthetic called “latex”? | NRL proteins are the Type I story; synthetics named “latex” do not release those proteins in NIOSH’s wording[^3][^10] | If unnamed, assume you cannot rule NRL **in or out** |
| Does labeling include a **device-style NRL caution** (801.437)? | Required for in-scope **devices**[^1] | Absence on fashion goods ≠ protein-free |
| Does the listing say **hypoallergenic**? | Banned on NR **devices** under 801.437(h);[^1] on fashion it is unregulated marketing | Not a Type I/IV clearance |
| Are **accelerator families** named or is an SDS available? | Type IV literacy is chemical families;[^7] SDS H317 is **class**, not diagnosis[^17] | Typical fashion silence |
| Any **protein method** cited (D5712 vs D6499)? | Method classes; D6499 antigenic ≠ proven allergenic correlation[^21][^13] | Fashion numbers rarely cited |
| Liquid latex work: **dipped/leached glove-lineage** stock or craft bottle? | Post-leach protein language is **gloves**[^11] | Do not assume glove QC |
| Sheet-based work: leach / protein / accelerator **certificate** for this **sheet lot**? | Fashion sheet dataset thin | Buy as unlabeled film, not as a medical device |
| “FDA” or **food-contact** on the card? | 177.2600 is food, not skin[^2] | Not a wear cert |
Makers cannot test wearers. Document what you actually know (NRL vs synthetic, SDS if you have one).
---
## When to stop and seek care
**Not medical advice. No treatment steps.**
Stop wearing or handling the article and seek a **qualified clinician** if you notice a new rash, hives, swelling, breathing difficulty, or any reaction you worry about after latex contact. Do not “challenge” the garment to confirm. Do not treat chlorination, shine, or a different oil as a cure.
---
## Deep dives (Advanced practitioner, optional)
**Still not medical advice.**
Deep dive: Accelerator chemical families (handbook map)
**phr** = parts per hundred rubber. Tables are **handbook examples, not craft recipes.**
Vanderbilt Table 1 types:[^14] thiuram, dithiocarbamate, xanthate, thiazole including sulfenamide, thiourea, guanidine. HPL Table 16.6 names zinc/sodium **xanthates** among the fastest latex sulfur-vulcanization accelerators.[^23]
Wilson patch series (clinic accelerators, not garment assay):[^23]
| Accelerator tested | Positive reactions (of 42 clinic patients) |
| --- | --- |
| Dipentamethylenethiuram disulphide | 30 |
| Tetramethylthiuram disulphide (TMTD class) | 20 |
| 2-Mercaptobenzthiazole (MBT) | 15 |
| Zinc diethyldithiocarbamate (ZDEC class) | 2 |
Surgeon-glove example (handbook, not craft recipe):[^11]
| Ingredient | phr (handbook) |
| --- | --- |
| 50% ZDEC/ZDBC | 0.50–0.85 |
| 50% ZMBT | 0.25–0.45 |
21 CFR 177.2600: accelerators total **not to exceed 1.5% by weight of rubber product**.[^2][^14] **Food-contact, not dermal clearance.**
Deep dive: Protein measurement method classes
| Method | What it reports | What it does **not** do |
| --- | --- | --- |
| ASTM D5712 (modified Lowry) | Total aqueous extractable protein (µg/dm² class) | Not allergen-specific; total protein ≠ clinical potency[^21] |
| ASTM D6499 | Antigenic (not necessarily allergenic) Hevea protein | Not a pass/fail “safe garment”[^13] |
| ISO 12243:2003 | Water-extractable protein in NR **medical gloves** | Does **not** address safety or labelling; non-glove extraction **not validated**[^20] |
Practical Guide Category 4: less than **200 µg total protein per gram dry weight** of latex.[^11]
Glove process: post-leach to minimize residual protein;[^11] defect = increased protein from insufficient leaching / high-protein latex.[^11]
ASTM D3578 (exam gloves): protein and antigenic protein among conformance tests.[^22]
Deep dive: Device labeling and powder history
801.437: (a) latex **proteins**; (b) devices with NR contacting humans; (d) bold caution; **(h) shall not contain “hypoallergenic”**; (j) misbranded if noncompliant.[^1]
1997 FR rationale:[^18] hypoallergenicity claims removed because Draize-type tests were inappropriate for protein sensitivity.
2016 powder ban:[^19] powdered surgeon’s / patient exam gloves and absorbable lubricating powder banned; non-powdered NRL gloves still under §801.437. NIOSH: powder binds proteins.[^3]
---
## Endnotes
[^1]: 21 CFR 801.437 — medical-device NRL labeling: protein hazard; required caution; (h) shall not contain “hypoallergenic”; (j) misbranding. Device scope, not fashion-garment duty.
[^2]: 21 CFR 177.2600 — rubber articles intended for repeated *food* contact; accelerator identity and total cap not to exceed 1.5% by weight of rubber product. Not a dermal wear or allergy certificate.
[^3]: NIOSH Pub. 97-135 (1997) — irritant vs delayed chemical (usually 24–48 h) vs immediate NRL-protein triad; synthetics ≠ NRL proteins; powder binds proteins. Workplace/occupational Alert, not fashion epidemiology.
[^4]: OSHA Hospitals eTool — Latex Allergy — three-way split; do not assume hypoallergenic or powderless gloves are non-latex; cites 801.437 in the hospital-glove setting.
[^5]: OSHA SHIB (28 Jan 2008) — points to NIOSH 97-135; NRL beyond exam gloves; still a workplace frame.
[^6]: Nguyen and Kohli, *StatPearls* (2023) — Hevea proteins → Type I; processing chemicals / antioxidants → Type IV (clinical secondary).
[^7]: Nucera et al., *J. Asthma Allergy* (2021) — Type IV family lists (carbamates, thiuram mix, 2-MBT, 1,3-diphenylguanidine; antioxidants among contactants).
[^8]: Pontén et al. (PMC5673089) — Type IV ACD from thiurams, carbamates, mercaptobenzothiazoles.
[^9]: AAAAI — Latex Allergy — public literacy: delayed-type often 12–36 h, usually added chemicals; immediate in previously sensitized people; anaphylaxis as *severe immediate* pattern. Treatment/epinephrine **not** copied.
[^10]: AAAAI — Latex Allergy Defined — immune overreaction to proteins in NRL; synthetic “latex” paints not shown to pose that protein hazard to latex-sensitive individuals.
[^11]: *Practical Guide to Latex Technology* — NR composition (proteins 1–1.5%; protein-lipid envelope); ammonia odor/discomfort; LATZ TMTD package; accelerator names; Category 4 D5712/D6499 names and <200 µg/g dry-weight prose; surgeon-glove Table 4.4 phr *example*; glove pre-/post-leach protein language and high-protein defect.
[^12]: NBS Letter Circular 321 — adsorbed protein layer / exterior protein shell and acid coagulation (1932 composition/history, not allergy medicine).
[^13]: ASTM D6499-24 — antigenic (not necessarily allergenic) Hevea protein method class; Type I proteins vs Type IV chemical additives in the significance statement.
[^14]: *The Vanderbilt Latex Handbook* — organic accelerators + ZnO; Table 1 families; 177.2600 food-contact identity reprint; coagulant-dip leach tank (required/circulate/no-reuse) and leach purpose.
[^15]: Buttazzo et al., *Allergo J Int.* (2021) — historical thiuram glove ACD; shift toward dithiocarbamates; thiuram↔dithiocarbamate redox / cross-reactivity.
[^16]: Hansen et al., *Contact Dermatitis* (2025) — pooled **dermatitis-clinic** prevalences. Clinic population, not garment wearers.
[^17]: Representative ZDEC SDS, CAS 14324-55-1 — GHS Skin Sens. 1; H317. Neat-chemical hazard class, not diagnosis of a worn garment.
[^18]: FDA, 62 FR 51021 (30 Sep 1997) — final rule rationale: NRL/dry NR device caution; hypoallergenicity claims removed.
[^19]: FDA, 81 FR 91722 (19 Dec 2016) / 21 CFR 895.102–.104 — ban on powdered surgeon’s / patient-exam gloves and absorbable lubricating powder; non-powdered NRL gloves still under §801.437.
[^20]: ISO 12243:2003 — water-extractable protein in NR **medical gloves**; does not address safety or labelling; non-glove extraction not validated.
[^21]: ASTM D5712-15(2020) — modified Lowry total aqueous extractable protein (method class).
[^22]: ASTM D3578 — exam-glove conformance includes protein / antigenic protein; not a fashion-sheet spec.
[^23]: *Polymer Latices Vol 3 — Application of Latices* (Blackley) — §16.3.3 xanthates; §16.3.4 thiazoles (ZMBT health-scrutiny language); §16.3.6 N-nitrosamine problem; §16.3.7 accelerator contact dermatitis (Wilson patch series, N=42 clinic patients); §17.4.1.2 human-body-contact dipped goods → minimize nitrosamines.